- The U.S. Food and Drug Administration on Friday authorized Moderna Inc’s shot for children aged six months to 5 yearsÂ
- Pfizer-BioNTech’s vaccine is approved for children aged six months to 4 yearsÂ
- President Joe Biden’s administration plans to roll out the vaccines to the under-5 age groups as early as next week
A panel of advisers to the U.S. Centers for Disease Control and Prevention on Saturday voted to recommend COVID-19 vaccines for children as young as six months, making it likely a nationwide rollout can start next week.
The 12-0 vote in favor of the move needs to be signed off by CDC Director Rochelle Walensky for the U.S. government to start rolling out the vaccines for children aged 5 and under.
The U.S. Food and Drug Administration on Friday authorized Moderna Inc’s shot for children aged six months to 5 years, and Pfizer-BioNTech’s vaccine for children aged six months to 4 years. Pfizer’s vaccine is already authorized for children over the age of 5.